ORMP — ORAMED PHARMACEUTICALS INC

Ownership history in XTX Topco Ltd · 9 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ORAMED PHARMACEUTICALS INC (ORMP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.15% (2022 Q4)

Avg. % of fund

0.04%

First filed

2021 Q4

Last filed

2025 Q4

Quarters held

9

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	ADDED	38,182	+14,297	+59.9%	0.00%	$109K	$2.66
2025 Q3	REDUCED	23,885	-831	-3.4%	0.00%	$63K	$2.46
2024 Q3	ADDED	24,716	+9,242	+59.7%	0.00%	$60K	$2.27
2024 Q2	REDUCED	15,474	-1,851	-10.7%	0.00%	$40K	$2.40

% of Fund (quarterly) ORMP price (monthly, adj. close)

Other funds also holding ORMP

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 7.8% SB Capital Management Inc 1.98% Murchinson Ltd. 3Y 0.61% Redwood Family Wealth LLC 0.06% BOOTHBAY FUND MANAGEMENT, LLC 3Y 7Y 0.03% Sage Capital Management, LLC 0.02% Glass Jacobson Investment Advisors llc 3Y 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.01% RBF Capital, LLC 3Y 7Y 0.01% PRELUDE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0%

← Back to XTX Topco Ltd Holdings